113 related articles for article (PubMed ID: 14611667)
1. Murine leukemia RL male 1 and sarcoma Meth A antigens recognized by cytotoxic T lymphocytes (CTL).
Uenaka A; Nakayama E
Cancer Sci; 2003 Nov; 94(11):931-6. PubMed ID: 14611667
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia.
Manki A; Ono T; Uenaka A; Seino Y; Nakayama E
Cancer Res; 1998 May; 58(9):1960-4. PubMed ID: 9581839
[TBL] [Abstract][Full Text] [Related]
3. Analysis of CD8 T-cell response by IFNgamma ELISPOT and H-2L(d)/pRL1a tetramer assays in pRL1a multiple antigen peptide-immunized and RL male 1-bearing BALB/c and (BALB/c x C57BL/6) F(1) mice.
Takada I; Noguchi Y; Kenjo A; Wada H; Uenaka A; Fujita T; Inoue H; Nakayama E
Cancer Sci; 2004 Mar; 95(3):254-9. PubMed ID: 15016326
[TBL] [Abstract][Full Text] [Related]
4. Diversity of epitopes recognized by cytotoxic T lymphocytes that are specific for rejection antigen peptide pRL1a presented on BALB/c leukemia RL Male 1.
Yokoi T; Uenaka A; Ono T; Onizuka S; Inoue H; Nakayama E
Int Immunol; 1997 Aug; 9(8):1195-201. PubMed ID: 9263017
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of autoreactive CD4 T cells in generation of cytotoxic T lymphocytes on in vitro stimulation with H-2 class I-binding tumor antigen peptide.
Honda S; Wada H; Uenaka A; Nakayama E
Int Immunol; 1998 Aug; 10(8):1167-74. PubMed ID: 9723703
[TBL] [Abstract][Full Text] [Related]
6. Identification of a CD4 T-cell epitope in tumor rejection antigen RLakt on BALB/c radiation-leukemia RL male 1.
Kaya S; Uenaka A; Sato S; Ono T; Aji T; Nakayama E
Cancer Sci; 2008 Jul; 99(7):1441-7. PubMed ID: 18452555
[TBL] [Abstract][Full Text] [Related]
7. Cryptic CTL epitope on a murine sarcoma Meth A generated by exon extension as a novel mechanism.
Uenaka A; Hirano Y; Hata H; Win S; Aji T; Tanaka M; Ono T; Skipper JC; Shimizu K; Nakayama E
J Immunol; 2003 May; 170(9):4862-8. PubMed ID: 12707369
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of RL male 1 tumor growth in BALB/c mice by introduction of the RLakt gene coding for antigen recognized by cytotoxic T-lymphocytes and the GM-CSF gene by in vivo electroporation.
Tanaka M; Yamada M; Ono T; Noguchi Y; Uenaka A; Ota S; Hata H; Harada M; Tanimoto M; Nakayama E
Cancer Sci; 2004 Feb; 95(2):154-9. PubMed ID: 14965366
[TBL] [Abstract][Full Text] [Related]
9. Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells.
Ota S; Ono T; Morita A; Uenaka A; Harada M; Nakayama E
Cancer Res; 2002 Mar; 62(5):1471-6. PubMed ID: 11888922
[TBL] [Abstract][Full Text] [Related]
10. Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene.
Uenaka A; Ono T; Akisawa T; Wada H; Yasuda T; Nakayama E
J Exp Med; 1994 Nov; 180(5):1599-607. PubMed ID: 7964448
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of tumor antigen pRL1a specific CD8 T cells in spleen cells from syngeneic BALB/c, semiallogeneic (BALB/c x C57BL/6)F1 and allogeneic C57BL/6 mice.
Hata H; Uenaka A; Takada I; Kenjo A; Takahashi M; Ono T; Fujita T; Nakayama E
Int J Oncol; 2002 May; 20(5):1019-25. PubMed ID: 11956599
[TBL] [Abstract][Full Text] [Related]
12. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
Matsuo M; Wada H; Honda S; Tawara I; Uenaka A; Kanematsu T; Nakayama E
J Immunol; 1999 Jun; 162(11):6420-5. PubMed ID: 10352255
[TBL] [Abstract][Full Text] [Related]
13. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
Frassanito MA; Mayordomo JI; DeLeo RM; Storkus WJ; Lotze MT; DeLeo AB
Cancer Res; 1995 Jan; 55(1):124-8. PubMed ID: 7528638
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cloned class I MHC-restricted, CD8+ anti-Meth A cytotoxic T-lymphocytes: recognition of an epitope derived from the Meth A gp110 tumor rejection antigen.
Fassanito MA; Loftus D; De Leo RM; Law LW; Appella E; De Leo AB
Cancer Res; 1994 Aug; 54(16):4424-9. PubMed ID: 7519121
[TBL] [Abstract][Full Text] [Related]
15. Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.
Morishita H; Shiku H; Horibe K; Obata Y; Stockert E; Oettgen HF; Old LJ; Yamada K
J Exp Med; 1986 Feb; 163(2):452-7. PubMed ID: 3003228
[TBL] [Abstract][Full Text] [Related]
16. ELISPOT cloning of tumor antigens recognized by cytotoxic T-lymphocytes from a cDNA expression library.
Uenaka A; Hata H; Win S; Ono T; Wada H; Nakayama E
Cancer Immun; 2001 Jul; 1():8. PubMed ID: 12747769
[TBL] [Abstract][Full Text] [Related]
17. Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.
Hendrickson RC; Cicinnati VR; Albers A; Dworacki G; Gambotto A; Pagliano O; Tüting T; Mayordomo JI; Visus C; Appella E; Shabanowitz J; Hunt DF; DeLeo AB
Cancer Immunol Immunother; 2010 Jan; 59(1):113-24. PubMed ID: 19562340
[TBL] [Abstract][Full Text] [Related]
18. Immunization with a carbohydrate mimicking peptide augments tumor-specific cellular responses.
Monzavi-Karbassi B; Cunto-Amesty G; Luo P; Shamloo S; Blaszcyk-Thurin M; Kieber-Emmons T
Int Immunol; 2001 Nov; 13(11):1361-71. PubMed ID: 11675368
[TBL] [Abstract][Full Text] [Related]
19. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.
Dudley ME; Roopenian DC
J Exp Med; 1996 Aug; 184(2):441-7. PubMed ID: 8760797
[TBL] [Abstract][Full Text] [Related]
20. Production of murine leukemia RLmale1 rejection antigen peptide pRL1a by proteolysis of natural precursor pRL1b.
Ono T; Uenaka A; Nakayama E
Jpn J Cancer Res; 1996 Nov; 87(11):1165-70. PubMed ID: 9045946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
